Abstract
Apolipoprotein(a) [apo(a)] displays a remarkable genetic heterogeneity of which the physiopathologic mechanisms are yet unknown. Its homology with plasminogen also suggests a pro-thrombotic role. To investigate whether or not lipoprotein(a) [Lp(a)] concentration and/or apo(a) isoforms correlate with the severity of diabetic retinopathy (DR), 113 Type II diabetic patients were studied. By fluorescein angiography, 3 classes of DR were considered: 'null' (40 subjects), 'non-proliferative' (37 subjects) and 'proliferative' (36 subjects). Apo(a) isoforms were detected by a capillary Western Blotting technique, resulting in the identification of 21 apo(a) isoforms with molecular weight (MW) varying from 400 to 775 kDa. Lp(a) plasma concentration did not correlate with the degree of DR (15.6 mg/dl in 'null', 17.8 mg/dl in 'non-proliferative' and 20.6 mg/dl in 'proliferative' DR group, p = 0.399). On the contrary, in subjects with proliferative DR there was a significant prevalence (65%) of low MW apo(a) isoforms (cut-off between 640 and 655 kDa), as compared to null DR (26%, p <0.01) and to non-proliferative DR (35%, p <0.05). In conclusion, low MW apo(a) isoforms could represent another possible biological marker of the genetic risk for the development and progression of retinal diabetic microangiopathy.
| Original language | English |
|---|---|
| Pages (from-to) | 129-137 |
| Number of pages | 9 |
| Journal | Diabetes, Nutrition and Metabolism - Clinical and Experimental |
| Volume | 9 |
| Issue number | 3 |
| Publication status | Published - 1996 |
Fingerprint
Keywords
- Apo(a) isoforms
- Diabetic retinopathy
- Lipoprotein(a)
- Microangiopathy
ASJC Scopus subject areas
- Food Science
- Endocrinology
- Medicine (miscellaneous)
- Endocrinology, Diabetes and Metabolism
- Internal Medicine
Cite this
Lipoprotein(a) and proliferative diabetic retinopathy in Type II diabetes mellitus : A role for isoforms with low molecular weight. / Buscaglia, P.; Gazzaruso, C.; Garzaniti, A.; Bonetti, G.; Porta, A.; Negri, A.; Vandelli, G.; Finardi, G.; Fratino, P.; Geroldi, D.
In: Diabetes, Nutrition and Metabolism - Clinical and Experimental, Vol. 9, No. 3, 1996, p. 129-137.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Lipoprotein(a) and proliferative diabetic retinopathy in Type II diabetes mellitus
T2 - A role for isoforms with low molecular weight
AU - Buscaglia, P.
AU - Gazzaruso, C.
AU - Garzaniti, A.
AU - Bonetti, G.
AU - Porta, A.
AU - Negri, A.
AU - Vandelli, G.
AU - Finardi, G.
AU - Fratino, P.
AU - Geroldi, D.
PY - 1996
Y1 - 1996
N2 - Apolipoprotein(a) [apo(a)] displays a remarkable genetic heterogeneity of which the physiopathologic mechanisms are yet unknown. Its homology with plasminogen also suggests a pro-thrombotic role. To investigate whether or not lipoprotein(a) [Lp(a)] concentration and/or apo(a) isoforms correlate with the severity of diabetic retinopathy (DR), 113 Type II diabetic patients were studied. By fluorescein angiography, 3 classes of DR were considered: 'null' (40 subjects), 'non-proliferative' (37 subjects) and 'proliferative' (36 subjects). Apo(a) isoforms were detected by a capillary Western Blotting technique, resulting in the identification of 21 apo(a) isoforms with molecular weight (MW) varying from 400 to 775 kDa. Lp(a) plasma concentration did not correlate with the degree of DR (15.6 mg/dl in 'null', 17.8 mg/dl in 'non-proliferative' and 20.6 mg/dl in 'proliferative' DR group, p = 0.399). On the contrary, in subjects with proliferative DR there was a significant prevalence (65%) of low MW apo(a) isoforms (cut-off between 640 and 655 kDa), as compared to null DR (26%, p <0.01) and to non-proliferative DR (35%, p <0.05). In conclusion, low MW apo(a) isoforms could represent another possible biological marker of the genetic risk for the development and progression of retinal diabetic microangiopathy.
AB - Apolipoprotein(a) [apo(a)] displays a remarkable genetic heterogeneity of which the physiopathologic mechanisms are yet unknown. Its homology with plasminogen also suggests a pro-thrombotic role. To investigate whether or not lipoprotein(a) [Lp(a)] concentration and/or apo(a) isoforms correlate with the severity of diabetic retinopathy (DR), 113 Type II diabetic patients were studied. By fluorescein angiography, 3 classes of DR were considered: 'null' (40 subjects), 'non-proliferative' (37 subjects) and 'proliferative' (36 subjects). Apo(a) isoforms were detected by a capillary Western Blotting technique, resulting in the identification of 21 apo(a) isoforms with molecular weight (MW) varying from 400 to 775 kDa. Lp(a) plasma concentration did not correlate with the degree of DR (15.6 mg/dl in 'null', 17.8 mg/dl in 'non-proliferative' and 20.6 mg/dl in 'proliferative' DR group, p = 0.399). On the contrary, in subjects with proliferative DR there was a significant prevalence (65%) of low MW apo(a) isoforms (cut-off between 640 and 655 kDa), as compared to null DR (26%, p <0.01) and to non-proliferative DR (35%, p <0.05). In conclusion, low MW apo(a) isoforms could represent another possible biological marker of the genetic risk for the development and progression of retinal diabetic microangiopathy.
KW - Apo(a) isoforms
KW - Diabetic retinopathy
KW - Lipoprotein(a)
KW - Microangiopathy
UR - http://www.scopus.com/inward/record.url?scp=8944258550&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=8944258550&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:8944258550
VL - 9
SP - 129
EP - 137
JO - Diabetes, Nutrition and Metabolism - Clinical and Experimental
JF - Diabetes, Nutrition and Metabolism - Clinical and Experimental
SN - 0394-3402
IS - 3
ER -